Synthesis and evaluation of CCR5 antagonists containing modified 4-piperidinyl-2-phenyl-1-(phenylsulfonylamino)-butane

Synthesis, CCR5 affinity and anti-HIV activity of analogs containing bicyclic piperidine replacements for 4-aminopiperidine moiety of the lead are described.